find care
Our team of compassionate, highly trained urologists provides comprehensive treatment options tailored to your individual needs. We’re here to guide you with expertise, respect, and care — every step of the way.
Texas Oncology is a leader in groundbreaking cancer research and clinical trials in Texas, paving the way for new breakthroughs in cancer care.
The cause of acute myeloid leukemia is unknown; however, research studies show that two-thirds of cancer deaths in the U.S. have been linked to lifestyle factors that can increase a patient’s risk, such as:
Diet
Diets high in ultra-processed foods and low in fruits and vegetables may promote chronic inflammation and oxidative stress, which are known contributors to cancer development, including blood cancers like AML.
Obesity
Obesity is associated with chronic inflammation and hormone imbalances, which can lead to environments favorable to AML.
Exercise
Higher levels of physical activity may reduce the occurrence of some cancers.
Alcohol consumption
Alcohol can damage the bone marrow and affect the production of blood cells, creating conditions that increase the risk of leukemia.
Smoking
Smoking introduces harmful chemicals to the body and blood stream, like benzene, which can damage DNA and lead to mutations in blood-forming cells.
Texas Oncology specialists are equipped to diagnose acute myeloid leukemia and may use the following tests:
A healthcare provider may perform a routine physical to identify signs and symptoms that may indicate a blood disorder, including AML.
A CBC is a common blood test that is performed during routine check-ups. It measures the different levels of cells in the blood, including white blood cells, red blood cells, and platelets. In AML, blood counts can be high or low, but are often low.
AML treatment is not one size fits all. That is why we personalize your treatment plan based on factors like subtype, age, medical history, general health, and treatment goals. Treatment options for AML may include:
This is the initial treatment phase of AML. The goal is to achieve a complete remission or disappearance of all detectable leukemia cells. This is often achieved through high-dose chemotherapy.
To prevent AML from returning, consolidation, a phase of treatment aimed at killing remaining cancer cells, is given immediately after recovery from remission induction therapy.
If a patient’s AML returns after remission induction and consolidation, they may undergo other treatment options, such as allogeneic stem cell transplant (a transplant where stem cells are from a donor) or chemotherapy.
Leading expertise
Our specialists trained at leading institutions across the country. They bring their extensive knowledge and skills of treating each case.
Leading-edge treatments
We offer the same treatments available at large academic centers, but in a community setting. For example, tyrosine kinase inhibitors work to stop leukemia cells from growing, while our immunotherapy program stimulates patients’ immune systems to attack cancer cells more effectively. Our active clinical trials program also gives eligible patients access to new treatments before they become widely available.
Customized care planning
Your diagnosis is only part of the picture. We listen to your concerns, honor your choices, and build a care experience that reflects your goals.
AML is a fast-growing cancer of the blood and bone marrow that happens when immature white blood cells overproduce. At Texas Oncology, our providers are equipped to diagnose and treat AML.
What sets Texas Oncology apart is our collaborative, patient-centered approach. With more than 550 physicians across the state, we offer access to a variety of treatments, from remission induction therapy to consolidation therapy. Our patients receive world-class care close to home.
When you seek care with us, you can expect a personalized care plan, a dedicated team alongside you, and the latest advancements in cancer treatment, all designed to support you.
The AML subtypes — which are based on cytogenetics, the study of chromosomes—are categorized into risk groups. The risk groups are determined by the specific chromosomal abnormalities.
The risk groups are:
It is not clear what the exact cause of acute myeloid leukemia is, but there are several risk factors that can increase the likelihood of developing AML:
Radiation
Exposure to large amounts of high-energy radiation increases the risk of AML by damaging DNA and disrupting cell growth. Patients with a condition requiring radiation therapy are also at increased risk of developing the disease.
Exposure to harmful chemicals
Harmful chemicals, like benzene, are associated with an increased leukemia risk. Benzene can be found in cigarette smoke, gasoline, chemical plants, shoe manufacturing, and some art supplies.
Smoking
Cancer-causing agents in tobacco smoke, like benzene, can enter the bloodstream and are associated with an increased risk of AML development.
Blood disorders
Blood disorders, such as Myeloidysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN), affect the body's ability to produce healthy blood cells. This can increase a patient’s risk of developing AML.
Genetic disorders
Certain genetic disorders, like Down syndrome, are associated with an increased risk of AML, partly due to changes in genes that regulate cell growth.
The cause of acute myeloid leukemia is unknown; however, research studies show that two-thirds of cancer deaths in the U.S. have been linked to lifestyle factors that can increase a patient’s risk, such as:
Diet
Diets high in ultra-processed foods and low in fruits and vegetables may promote chronic inflammation and oxidative stress, which are known contributors to cancer development, including blood cancers like AML.
Obesity
Obesity is associated with chronic inflammation and hormone imbalances, which can lead to environments favorable to AML.
Exercise
Higher levels of physical activity may reduce the occurrence of some cancers.
Alcohol consumption
Alcohol can damage the bone marrow and affect the production of blood cells, creating conditions that increase the risk of leukemia.
Smoking
Smoking introduces harmful chemicals to the body and blood stream, like benzene, which can damage DNA and lead to mutations in blood-forming cells.
Several signs and symptoms could indicate acute myeloid leukemia. If you notice that any of the AML symptoms keep returning or worsen over time, talk with your doctor as soon as possible. That way, you can rule out whether your symptoms are caused by AML or other conditions.
Texas Oncology specialists are equipped to diagnose acute myeloid leukemia and may use the following tests:
A healthcare provider may perform a routine physical to identify signs and symptoms that may indicate a blood disorder, including AML.
A CBC is a common blood test that is performed during routine check-ups. It measures the different levels of cells in the blood, including white blood cells, red blood cells, and platelets. In AML, blood counts can be high or low, but are often low.
AML treatment is not one size fits all. That is why we personalize your treatment plan based on factors like subtype, age, medical history, general health, and treatment goals. Treatment options for AML may include:
This is the initial treatment phase of AML. The goal is to achieve a complete remission or disappearance of all detectable leukemia cells. This is often achieved through high-dose chemotherapy.
To prevent AML from returning, consolidation, a phase of treatment aimed at killing remaining cancer cells, is given immediately after recovery from remission induction therapy.
If a patient’s AML returns after remission induction and consolidation, they may undergo other treatment options, such as allogeneic stem cell transplant (a transplant where stem cells are from a donor) or chemotherapy.
Leading expertise
Our specialists trained at leading institutions across the country. They bring their extensive knowledge and skills of treating each case.
Leading-edge treatments
We offer the same treatments available at large academic centers, but in a community setting. For example, tyrosine kinase inhibitors work to stop leukemia cells from growing, while our immunotherapy program stimulates patients’ immune systems to attack cancer cells more effectively. Our active clinical trials program also gives eligible patients access to new treatments before they become widely available.
Customized care planning
Your diagnosis is only part of the picture. We listen to your concerns, honor your choices, and build a care experience that reflects your goals.
